| 2026-09-10 | Label | FDA label revised: Calcitonin Salmon (ANDA076396) | Regulator FDA drug label register |
| 2026-08-12 | Trial | New trial registered: Effect of Nebulized Dexmedetomidine on Central Sensitization and Chronification in Migraine | Trial register ClinicalTrials.gov |
| 2026-07-29 | Federal Register | Federal Register notice: Product-Specific Guidances; Revised Draft Guidances for Industry; Availability | Regulator Federal Register |
| 2026-07-15 | Label | FDA label revised: Calcitonin Salmon (ANDA212675) | Regulator FDA drug label register |
| 2026-06-30 | Trial | New trial registered: Long-term Atogepant in Real-world Practice | Trial register ClinicalTrials.gov |
| 2026-06-29 | Label | FDA label revised: CALCITONIN SALMON (ANDA076979) | Regulator FDA drug label register |
| 2026-06-18 | Trial | New trial registered: Subcutaneous Calcitonin in Acute Herpes Zoster | Trial register ClinicalTrials.gov |
| 2026-06-17 | Trial | New trial registered: Calcitonin Gene-related Peptide Antibody in Acute Mountain Sickness | Trial register ClinicalTrials.gov |
| 2026-06-09 | Trial | New trial registered: Eptinezumab for Chronic Headache in Idiopathic Intracranial Hypertension | Trial register ClinicalTrials.gov |
| 2026-05-23 | Trial | New trial registered: Mulligan Mobilization and Stabilization Exercises for Sensorimotor Function in Women With Text Neck Syndrome | Trial register ClinicalTrials.gov |
| 2026-05-18 | Trial | New trial registered: STAGE-MTC Trial Thyroid Lobectomy With Ipsilateral Central Neck Dissection | Trial register ClinicalTrials.gov |
| 2026-04-28 | Trial | New trial registered: Using Virtual Reality to Teach Mindfulness to People With Migraine | Trial register ClinicalTrials.gov |
| 2026-03-06 | Label | FDA label revised: CALCITONIN SALMON (ANDA215864) | Regulator FDA drug label register |
| 2026-03-06 | Label | FDA label revised: CALCITONIN SALMON (ANDA215864) | Regulator FDA drug label register |
| 2026-02-24 | Trial | New trial registered: Different Kinematics Within a Single-File System and Postoperative Pain | Trial register ClinicalTrials.gov |
| 2026-02-12 | Results | Results posted: Yield of Diagnostic Tests and Effects of Crofelemer for Chronic Idiopathic Diarrhea In Non-HIV Patients | Trial register ClinicalTrials.gov |
| 2025-12-16 | Results | Results posted: Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens | Trial register ClinicalTrials.gov |
| 2025-12-12 | Trial | New trial registered: Evaluation of Pulpal and Salivary Neuropeptides in Dental Pain | Trial register ClinicalTrials.gov |
| 2025-12-05 | Federal Register | Federal Register notice: Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability | Regulator Federal Register |
| 2025-11-21 | Trial | New trial registered: A Study to Compare Blood Levels of Different Dosage Formulations of the Study Medicine That Is a CGRP Receptor Antagonist in Healthy Adults | Trial register ClinicalTrials.gov |
| 2025-09-24 | Trial | New trial registered: Chinese Real-world Study of Treatment of Vestibular Migraine | Trial register ClinicalTrials.gov |
| 2025-09-17 | Label | FDA label revised: Calcitonin Salmon (ANDA215715) | Regulator FDA drug label register |
| 2025-09-09 | Label | FDA label revised: Calcitonin Salmon (ANDA219196) | Regulator FDA drug label register |
| 2025-08-23 | Trial | New trial registered: Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine | Trial register ClinicalTrials.gov |
| 2025-07-30 | Label | FDA label revised: CALCITONIN SALMON (ANDA213766) | Regulator FDA drug label register |
| 2025-06-24 | Trial | New trial registered: Adding Calcitonin to Bupivacaine in Transversalis Fascia Plane Block for Cesarean Section | Trial register ClinicalTrials.gov |
| 2025-06-19 | Trial | New trial registered: Plasma Calcitonin Gene-Related Peptide (CGRP) Levels in Patients With Head and Neck Malignancies Undergoing Radiotherapy | Trial register ClinicalTrials.gov |
| 2025-06-15 | Trial | New trial registered: Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide | Trial register ClinicalTrials.gov |
| 2025-04-29 | Trial | New trial registered: i-NEED: NEw migrainE Drugs Database | Trial register ClinicalTrials.gov |
| 2025-02-05 | Trial | New trial registered: Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis | Trial register ClinicalTrials.gov |
| 2024-10-29 | Trial | New trial registered: Ultrasound Guided Block of Stellate Ganglion Versus Greater Occipital Nerve in Resistant Migraine and Correlation to Calcitonin Gene Related Peptide | Trial register ClinicalTrials.gov |
| 2024-09-15 | Label | FDA label revised: Miacalcin (NDA017808) | Regulator FDA drug label register |
| 2024-09-15 | Label | FDA label revised: Miacalcin (NDA017808) | Regulator FDA drug label register |
| 2024-08-08 | Trial | New trial registered: Biochemical Profiling of Migraine Patients | Trial register ClinicalTrials.gov |
| 2024-08-08 | Trial | New trial registered: Searching for Novel Therapeutic Approaches in Migraine Patients Resistant to Treatments | Trial register ClinicalTrials.gov |
| 2024-08-08 | Trial | New trial registered: Searching for Novel Biological Phenotypes in Migraine Patients Resistant to Treatments | Trial register ClinicalTrials.gov |
| 2024-07-19 | Trial | New trial registered: Evaluation of the Levels of Calcitonin Gene-related Peptide and Substance P | Trial register ClinicalTrials.gov |
| 2024-07-10 | Label | FDA label revised: Calcitonin Salmon (ANDA212416) | Regulator FDA drug label register |
| 2024-07-09 | Results | Results posted: QUILT-3.006 for Recurrent Medullary Thyroid Cancer | Trial register ClinicalTrials.gov |
| 2024-06-11 | Results | Results posted: The Use of Intranasal Calcitonin to Improve Pain and Activity in Elderly Pelvic Ring Injuries | Trial register ClinicalTrials.gov |
| 2024-05-29 | Results | Results posted: Real World Effectiveness of Eptinezumab in Participants With Migraine | Trial register ClinicalTrials.gov |
| 2024-04-15 | Label | FDA label revised: Miacalcin (NDA017808) | Regulator FDA drug label register |
| 2024-04-02 | Results | Results posted: Erenumab-aooe for Temporomandibular Disorders Management: TMD Cgrp Antibody RElief (TMD CARE) | Trial register ClinicalTrials.gov |
| 2024-03-26 | Trial | New trial registered: Paravertebral Calcitonin in Thoracotomy | Trial register ClinicalTrials.gov |
| 2024-03-22 | Results | Results posted: Erenumab-aooe for the Management of Trigeminal Neuropathic Pain. | Trial register ClinicalTrials.gov |
| 2024-02-13 | Trial | New trial registered: Real-world Effectiveness and Tolerability of Triptans-Ditans-Gepants (TRIDIGEP) | Trial register ClinicalTrials.gov |
| 2024-02-13 | Trial | New trial registered: Role of PCO2 Gap as Predictor of Clinical Outcome in ICU Septic Patients | Trial register ClinicalTrials.gov |
| 2023-11-23 | Trial | New trial registered: HD-EEG Connectivity Changes in Migraine Patients Undergoing Treatment With Anti-CGRP mAbs | Trial register ClinicalTrials.gov |
| 2023-10-05 | Trial | New trial registered: Calcitonin in Needle Wash Using Electrochemiluminescence Method For Diagnosis Of Medullary Thyroid Carcinoma. | Trial register ClinicalTrials.gov |
| 2023-07-26 | Trial | New trial registered: Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiving CGRP Therapy (ReMMiD-C) | Trial register ClinicalTrials.gov |
| 2023-07-21 | Trial | New trial registered: Use of Procalcitonin, a Blood Test to Guide Antibiotic Therapy for Sepsis in Adults | Trial register ClinicalTrials.gov |
| 2023-06-08 | Trial | New trial registered: Evaluate the Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Antagonists in Patients With Dry Eye Disease and Asthenopia | Trial register ClinicalTrials.gov |
| 2023-05-17 | Recall | FDA recall, Class II: Apotex Corp.. Presence of Foreign Substance: Glass splinter particle entrapped inside the pump ball seat rendered the pump inoperable. | Regulator FDA enforcement reports |
| 2023-04-10 | Trial | New trial registered: Calcitonin Therapy on Incidence and Severity of Neuropathic Pain After Spinal Cord Injury | Trial register ClinicalTrials.gov |
| 2023-04-05 | Recall | FDA recall, Class II: Endo Pharmaceuticals, Inc.. Failed Impurities/Degradation Specifications and Subpotent Drug: High Out of Specification results for a known and unkno | Regulator FDA enforcement reports |
| 2023-04-03 | Trial | New trial registered: PROcalcitonin and Presepsin-guided Decision for Antibiotic Prophylaxis of EOS | Trial register ClinicalTrials.gov |
| 2023-03-27 | Trial | New trial registered: RecoveryPlus Telerehab Platform Pilot Study | Trial register ClinicalTrials.gov |
| 2023-03-14 | Trial | New trial registered: Stimulation-evoked Calcitonin Gene-Related Peptide (CGRP) as Biomarker of Migraine | Trial register ClinicalTrials.gov |
| 2023-03-11 | Trial | New trial registered: Anti-CGRP Monoclonal Antibody Response After Switching (AMARAS) | Trial register ClinicalTrials.gov |
| 2023-03-01 | Trial | New trial registered: Chasing Biomarkers in Post-concussion Syndrome | Trial register ClinicalTrials.gov |
| 2023-02-17 | Federal Register | Federal Register notice: Determination That MIACALCIN (Calcitonin Salmon) Injection, 100 USP Units/Milliliter (mL), Was Not Withdrawn From Sale for Reasons of Safety or E | Regulator Federal Register |
| 2023-01-11 | Trial | New trial registered: Denosumab Treatment in CKD Patients at High Risk of Fracture | Trial register ClinicalTrials.gov |
| 2022-11-30 | Trial | New trial registered: The Lacosamide's Effect on Calcitonin Gene-related Peptide in Migraine Patients | Trial register ClinicalTrials.gov |
| 2022-11-18 | Federal Register | Federal Register notice: Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability | Regulator Federal Register |
| 2022-11-15 | Label | FDA label listed: GUNA-ARTHRO | Company says FDA drug label register |
| 2022-11-15 | Trial | New trial registered: Migraine Induction Properties of PACAP-38 After Eptinezumab in Migraine Without Aura Patients. | Trial register ClinicalTrials.gov |
| 2022-11-14 | Label | FDA label listed: OSTEOBIOS | Company says FDA drug label register |
| 2022-10-04 | Trial | New trial registered: EptinezuMaB in ReAl-world evidenCE: Multicenter, Real Life, Cohort Study in Migraine. | Trial register ClinicalTrials.gov |
| 2022-08-05 | Trial | New trial registered: Tandem OnabotulinumtoxinA Galcanezumab Emerging Therapeutic Headache Elimination Research Study | Trial register ClinicalTrials.gov |
| 2022-06-28 | Trial | New trial registered: Predictive Role of MIDAS Reduction at 3 Months for Erenumab Treatment | Trial register ClinicalTrials.gov |
| 2022-05-02 | Trial | New trial registered: Post-fracture Medication and Mortality | Trial register ClinicalTrials.gov |
| 2022-03-19 | Trial | New trial registered: LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions | Trial register ClinicalTrials.gov |
| 2022-02-23 | Trial | New trial registered: Real World Effectiveness of Eptinezumab in Participants With Migraine | Trial register ClinicalTrials.gov |
| 2022-02-02 | Federal Register | Federal Register notice: Hikma Pharmaceuticals USA, Inc., et al.; Withdrawal of Approval of 29 New Drug Applications | Regulator Federal Register |
| 2022-01-20 | Trial | New trial registered: Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens | Trial register ClinicalTrials.gov |
| 2021-11-30 | Label | FDA label revised: calcitonin salmon (ANDA216294) | Regulator FDA drug label register |
| 2021-11-19 | Trial | New trial registered: Occurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV Infection | Trial register ClinicalTrials.gov |
| 2021-10-29 | Trial | New trial registered: Erenumab-aooe for Temporomandibular Disorders Management: TMD Cgrp Antibody RElief (TMD CARE) | Trial register ClinicalTrials.gov |
| 2021-10-29 | Trial | New trial registered: Erenumab-aooe for the Management of Trigeminal Neuropathic Pain. | Trial register ClinicalTrials.gov |
| 2021-08-09 | Results | Results posted: Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine | Trial register ClinicalTrials.gov |
| 2021-08-06 | Trial | New trial registered: Calcitonin Level and New-onset of Post-Operative Atrial Fibrillation | Trial register ClinicalTrials.gov |
| 2021-06-10 | Results | Results posted: Hypothyroidism Treated With Calcitonin | Trial register ClinicalTrials.gov |
| 2021-05-11 | Trial | New trial registered: Calcitonin Gene-related Peptide Expression in Human Periodontal Ligament | Trial register ClinicalTrials.gov |
| 2021-03-09 | Results | Results posted: Study of Efficacy and Safety of AMG 334 in Adult Episodic Migraine Patients | Trial register ClinicalTrials.gov |
| 2021-03-01 | Trial | New trial registered: Human Electrophysiological Model to Quantify the CGRP-related Axon Reflex of Trigeminal Afferents | Trial register ClinicalTrials.gov |
| 2021-01-22 | Results | Results posted: Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer | Trial register ClinicalTrials.gov |
| 2020-11-05 | Trial | New trial registered: CGRP Inhibition, Autonomic Function, and Migraine | Trial register ClinicalTrials.gov |
| 2020-10-21 | Federal Register | Federal Register notice: Determination That BUTISOL SODIUM (Butabarbital Sodium) Oral Tablets, 15 Milligrams, 50 Milligrams, and 100 Milligrams, and Other Drug Products W | Regulator Federal Register |
| 2020-10-19 | Trial | New trial registered: Hypersensitivity to CGRP as a Predictive Biomarker of Migraine Prevention With Erenumab | Trial register ClinicalTrials.gov |
| 2020-07-01 | Trial | New trial registered: The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine | Trial register ClinicalTrials.gov |
| 2020-06-24 | Trial | New trial registered: Efficacy of Coadministration of Calcitonin and Hyperbaric Bupivacaine in Spinal Anesthesia in Tramadol-abuse Patients | Trial register ClinicalTrials.gov |
| 2020-04-06 | Trial | New trial registered: Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia | Trial register ClinicalTrials.gov |
| 2020-03-03 | Federal Register | Federal Register notice: Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability | Regulator Federal Register |
| 2020-02-05 | Trial | New trial registered: New Daily Persistent Headache Biomarkers Study | Trial register ClinicalTrials.gov |
| 2019-12-20 | Trial | New trial registered: Repeat Dosing of Psilocybin in Migraine Headache | Trial register ClinicalTrials.gov |
| 2019-09-09 | Federal Register | Federal Register notice: Determination That CALCIMAR (calcitonin salmon) Injection, 200 International Units Per Milliliter, Was Not Withdrawn From Sale for Reasons of Saf | Regulator Federal Register |
| 2019-08-20 | Trial | New trial registered: Evaluation of Efficacy and Safety of add-on Alpha-lipoic Acid on Migraine Prophylaxis in Adolescent Population | Trial register ClinicalTrials.gov |
| 2019-07-15 | Trial | New trial registered: Neurophysiology of Prophylactic Treatment in Migraine | Trial register ClinicalTrials.gov |
| 2019-05-02 | Trial | New trial registered: Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity | Trial register ClinicalTrials.gov |
| 2019-04-23 | Trial | New trial registered: Diagnostic Values of C-reactive Protein and Procalcitonin in Predicting Bacterial Infection in Acute Exacerbations of Chronic Obstructive Pulmonary | Trial register ClinicalTrials.gov |